<?xml version='1.0' encoding='utf-8'?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-us"><title>Docket updates for IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://michaellee50.github.io/CourtListener/feed-MDL-No.-3094.xml" rel="self" type="application/atom+xml" /><link href="https://www.courtlistener.com/" rel="alternate" /><link href="https://www.courtlistener.com/docket/68082231/feed/" rel="self" /><id>https://www.courtlistener.com/</id><updated>2025-12-29T00:00:00-08:00</updated><author><name>Free Law Project</name><email>feeds@courtlistener.com</email></author><rights>Created for the public domain by Free Law Project</rights><entry><title>Entry #390 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-390" rel="alternate" /><published>2025-12-29T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-390</id><summary type="html">Conditional Transfer Order Finalized</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001527457?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-29T00:00:00-08:00</updated></entry><entry><title>Minute entry from 2025-12-19 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-12-19T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-448674192</id><summary type="html">XYZ Cases Entered</summary><updated>2025-12-19T00:00:00-08:00</updated></entry><entry><title>Entry #389 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-389" rel="alternate" /><published>2025-12-17T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-389</id><summary type="html">Notice of Filing of CTO and Publication of Briefing Schedule</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?389,1674416,,," length="0" rel="enclosure" /><updated>2025-12-17T00:00:00-08:00</updated></entry><entry><title>Entry #388 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-388" rel="alternate" /><published>2025-12-17T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-388</id><summary type="html">Conditional Transfer Order Filed Today</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001526555?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-17T00:00:00-08:00</updated></entry><entry><title>Entry #387 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-387" rel="alternate" /><published>2025-12-16T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-387</id><summary type="html">Notice of Potential Tag-Along</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001526360?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-16T00:00:00-08:00</updated></entry><entry><title>Entry #386 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-386" rel="alternate" /><published>2025-12-16T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-386</id><summary type="html">Notice of Filing of CTO and Publication of Briefing Schedule</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?386,1674416,,," length="0" rel="enclosure" /><updated>2025-12-16T00:00:00-08:00</updated></entry><entry><title>Entry #385 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-385" rel="alternate" /><published>2025-12-16T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-385</id><summary type="html">Conditional Transfer Order Filed Today</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001526313?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-16T00:00:00-08:00</updated></entry><entry><title>Entry #384 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-384" rel="alternate" /><published>2025-12-16T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-384</id><summary type="html">Conditional Transfer Order Finalized</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001526278?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-16T00:00:00-08:00</updated></entry><entry><title>Entry #383 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-383" rel="alternate" /><published>2025-12-15T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-383</id><summary type="html">Notice of Potential Tag-Along</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001526112?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-15T00:00:00-08:00</updated></entry><entry><title>Entry #382 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-382" rel="alternate" /><published>2025-12-11T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-382</id><summary type="html">Conditional Transfer Order Finalized</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001525575?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-11T00:00:00-08:00</updated></entry><entry><title>Minute entry from 2025-12-10 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-12-10T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-448674183</id><summary type="html">XYZ Cases Entered</summary><updated>2025-12-10T00:00:00-08:00</updated></entry><entry><title>Entry #381 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-381" rel="alternate" /><published>2025-12-08T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-381</id><summary type="html">Notice of Filing of CTO and Publication of Briefing Schedule</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?381,1674416,,," length="0" rel="enclosure" /><updated>2025-12-08T00:00:00-08:00</updated></entry><entry><title>Entry #380 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-380" rel="alternate" /><published>2025-12-08T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-380</id><summary type="html">Conditional Transfer Order Filed Today</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001525046?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-08T00:00:00-08:00</updated></entry><entry><title>Entry #379 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-379" rel="alternate" /><published>2025-12-05T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-379</id><summary type="html">Notice of Potential Tag-Along</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001524911?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-05T00:00:00-08:00</updated></entry><entry><title>Minute entry from 2025-12-05 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-12-05T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-448674179</id><summary type="html">XYZ Cases Entered</summary><updated>2025-12-05T00:00:00-08:00</updated></entry><entry><title>Entry #378 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-378" rel="alternate" /><published>2025-12-04T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-378</id><summary type="html">Conditional Transfer Order Finalized</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001524582?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-04T00:00:00-08:00</updated></entry><entry><title>Minute entry from 2025-12-04 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/IN-RE:-Glucagon-like-Peptide-1 Receptor-Agonists-(GLP-1-RAs)-Products-LiabilityLitigation-(MDL-No.-3094)/" rel="alternate" /><published>2025-12-04T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#minute-entry-448674177</id><summary type="html">XYZ Cases Entered</summary><updated>2025-12-04T00:00:00-08:00</updated></entry><entry><title>Entry #377 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-377" rel="alternate" /><published>2025-12-03T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-377</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-45) re: pldg. ( 376 in MDL No. 3094, 1 in NJ/3:25-cv-17963, 1 in NJ/3:25-cv-17967, 1 in NJ/3:25-cv-17971, 1 in NJ/3:25-cv-17974, 1 in NJ/3:25-cv-18064, 1 in NJ/3:25-cv-18075, 1 in NJ/3:25-cv-18076) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 12/10/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 12/3/2025. Associated Cases: MDL No. 3094, NJ/3:25-cv-17963, NJ/3:25-cv-17967, NJ/3:25-cv-17971, NJ/3:25-cv-17974, NJ/3:25-cv-18064, NJ/3:25-cv-18075, NJ/3:25-cv-18076 (CT) (Entered: 12/03/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?377,1674416,,," length="0" rel="enclosure" /><updated>2025-12-03T00:00:00-08:00</updated></entry><entry><title>Entry #376 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-376" rel="alternate" /><published>2025-12-03T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-376</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-45) - 7 action(s) Signed by Clerk of the Panel James V. Ingold on 12/3/2025. Associated Cases: MDL No. 3094, NJ/3:25-cv-17963, NJ/3:25-cv-17967, NJ/3:25-cv-17971, NJ/3:25-cv-17974, NJ/3:25-cv-18064, NJ/3:25-cv-18075, NJ/3:25-cv-18076 (CT) (Entered: 12/03/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001524278?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-03T00:00:00-08:00</updated></entry><entry><title>Entry #375 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-375" rel="alternate" /><published>2025-12-02T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-375</id><summary type="html">DOCUMENT (AMENDED) - Filed by Plaintiff Burnice Davis Associated Cases: MDL No. 3094, ALM/1:25-cv-00739 (McGowan, Stephen) (Entered: 12/02/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001524236?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-02T00:00:00-08:00</updated></entry><entry><title>Entry #374 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-374" rel="alternate" /><published>2025-12-02T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-374</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 2 Action(s) -- Filed by attorney Diana M. Watral, P.C., counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- New Jersey District Court (2:25-cv-18075,2:25-cv-18076) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint- DNJ 2:25-cv-18075, # 4 Complaint- DNJ 2:25-cv-18076) (Watral, Diana) (Entered: 12/02/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001524066?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-02T00:00:00-08:00</updated></entry><entry><title>Entry #373 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-373" rel="alternate" /><published>2025-12-02T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-373</id><summary type="html">CONDITIONAL TRANSFER ORDER FINALIZED (CTO-43) - 3 action(s) re: pldg. (1 in INS/1:25-cv-02376, 1 in KYW/3:25-cv-00733, 366 in MDL No. 3094, 1 in NJ/3:25-cv-17639) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 12/2/2025. Associated Cases: MDL No. 3094, INS/1:25-cv-02376, KYW/3:25-cv-00733, NJ/3:25-cv-17639 (CT) (Entered: 12/02/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001524009?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-02T00:00:00-08:00</updated></entry><entry><title>Entry #372 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-372" rel="alternate" /><published>2025-12-01T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-372</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 1 Action(s) -- Filed by attorney Diana M. Watral, P.C., counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- New Jersey District Court (3:25-cv-18064) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint - 3:25-cv-18064) (Watral, Diana) (Entered: 12/01/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001523972?caseid=1674416" length="0" rel="enclosure" /><updated>2025-12-01T00:00:00-08:00</updated></entry><entry><title>Entry #371 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-371" rel="alternate" /><published>2025-11-26T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-371</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 4 Action(s) -- Filed by attorney Diana M. Watra, counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- New Jersey District Court (3:25-cv-17967,3:25-cv-17963,3:25-cv-17971,3:25-cv-17974) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint 3:25-cv-17963, # 4 Complaint 3:25-cv-17967, # 5 Complaint 3:25-cv-17971, # 6 Complaint 3:25-cv-17974) (Watral, Diana) Modified on 12/1/2025 (CT). ADDED PARTY TYPE. Modified on 12/1/2025 (CT). (Entered: 11/26/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001523717?caseid=1674416" length="0" rel="enclosure" /><updated>2025-11-26T00:00:00-08:00</updated></entry><entry><title>Entry #370 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-370" rel="alternate" /><published>2025-11-26T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-370</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-44) re: pldg. ( 369 in MDL No. 3094, 1 in NJ/3:25-cv-17893) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 12/3/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 11/26/2025. Associated Cases: MDL No. 3094, NJ/3:25-cv-17893 (CT) (Entered: 11/26/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?370,1674416,,," length="0" rel="enclosure" /><updated>2025-11-26T00:00:00-08:00</updated></entry><entry><title>Entry #369 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-369" rel="alternate" /><published>2025-11-26T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-369</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-44) - 1 action(s) Signed by Clerk of the Panel James V. Ingold on 11/26/2025. Associated Cases: MDL No. 3094, NJ/3:25-cv-17893 (CT) (Entered: 11/26/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001523552?caseid=1674416" length="0" rel="enclosure" /><updated>2025-11-26T00:00:00-08:00</updated></entry><entry><title>Entry #368 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-368" rel="alternate" /><published>2025-11-24T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-368</id><summary type="html">NOTICE OF POTENTIAL TAG-ALONG -- 1 Action(s) -- Filed by attorney Diana M. Watral, P.C., counsel for Defendants Eli Lilly and Company and Lilly USA, LLC -- New Jersey District Court (2:25-cv-17893) (Attachments: # 1 Schedule of Actions, # 2 Proof of Service, # 3 Complaint- DNJ 2:25-17893) (Watral, Diana) (Entered: 11/24/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001523341?caseid=1674416" length="0" rel="enclosure" /><updated>2025-11-24T00:00:00-08:00</updated></entry><entry><title>Entry #367 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-367" rel="alternate" /><published>2025-11-21T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-367</id><summary type="html">***TEXT ONLY NOTICE******A PROOF OF SERVICE IS REQUIRED FOR ALL FILINGS***NOTICE OF FILING OF CTO AND PUBLICATION OF BRIEFING SCHEDULE (CTO-43) re: pldg. (1 in INS/1:25-cv-02376, 1 in KYW/3:25-cv-00733, 366 in MDL No. 3094, 1 in NJ/3:25-cv-17639) BRIEFING SCHEDULE IS SET AS FOLLOWS: Oppositions due on or before 12/1/2025.Attorneys must be registered to file in the JPML. Please visit our website for Registration Information. Signed by Clerk of the Panel James V. Ingold on 11/21/2025. Associated Cases: MDL No. 3094, INS/1:25-cv-02376, KYW/3:25-cv-00733, NJ/3:25-cv-17639 (CT) (Entered: 11/21/2025)</summary><link href="https://ecf.jpml.uscourts.gov/cgi-bin/show_case_doc?367,1674416,,," length="0" rel="enclosure" /><updated>2025-11-21T00:00:00-08:00</updated></entry><entry><title>Entry #366 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-366" rel="alternate" /><published>2025-11-21T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-366</id><summary type="html">CONDITIONAL TRANSFER ORDER FILED TODAY (CTO-43) - 3 action(s) Signed by Clerk of the Panel James V. Ingold on 11/21/2025. Associated Cases: MDL No. 3094, INS/1:25-cv-02376, KYW/3:25-cv-00733, NJ/3:25-cv-17639 (CT) (Entered: 11/21/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001523062?caseid=1674416" length="0" rel="enclosure" /><updated>2025-11-21T00:00:00-08:00</updated></entry><entry><title>Entry #365 in IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094</title><link href="https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-365" rel="alternate" /><published>2025-11-21T00:00:00-08:00</published><id>https://www.courtlistener.com/docket/68082231/in-re-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-products/?order_by=desc#entry-365</id><summary type="html">CONDITIONAL TRANSFER ORDER FINALIZED (CTO-42) - 1 action(s) re: pldg. ( 360 in MDL No. 3094, 1 in NJ/3:25-cv-17338) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 11/21/2025. Associated Cases: MDL No. 3094, NJ/3:25-cv-17338 (CT) (Entered: 11/21/2025)</summary><link href="https://ecf.jpml.uscourts.gov/doc1/85001522959?caseid=1674416" length="0" rel="enclosure" /><updated>2025-11-21T00:00:00-08:00</updated></entry></feed>